DEVARTLab has officially announced its upcoming expansion into the Saudi Arabian market with the launch of its groundbreaking skincare innovation, Exotropin, in partnership with the renowned U.S.-based biotechnology company Exotropin Inc., a global leader in exosome-based solutions and biological research.
Exotropin marks a major leap in the field of advanced skincare. Powered by active exosome technology extracted from both plant and human stem cell sources, this formulation effectively delivers proteins and nutrients deep into the skin cells, enhancing natural regeneration and promoting a healthy, youthful appearance.
According to company management, this strategic move aligns with DEVARTLab’s broader vision to strengthen its footprint across the Gulf region and introduce cutting-edge beauty and wellness innovations. The formula is designed to address widespread skin concerns such as wrinkles, pigmentation, and dryness, with a thermally stable composition that requires no refrigeration, making it ideal for clinical use as well as individual daily routines.
The Exotropin line will soon be available at authorized retailers across Saudi Arabia, reinforcing DEVARTLab’s commitment to offering safe, science-backed, and effective skincare products that meet the region’s growing demand for premium beauty solutions.